BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27346669)

  • 1. Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.
    Blair NF; Barker RA
    Regen Med; 2016 Jul; 11(5):423-5. PubMed ID: 27346669
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced pluripotent stem cell technology for the study of human disease.
    Lee G; Studer L
    Nat Methods; 2010 Jan; 7(1):25-7. PubMed ID: 20038952
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cells: A path towards improved epilepsy therapies.
    Lybrand ZR; Goswami S; Hsieh J
    Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease.
    Abeliovich A; Doege CA
    Neuron; 2009 Feb; 61(3):337-9. PubMed ID: 19217371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cell (iPSC)-Derived Exosomes for Precision Medicine in Heart Failure.
    Yang PC
    Circ Res; 2018 Mar; 122(5):661-663. PubMed ID: 29496797
    [No Abstract]   [Full Text] [Related]  

  • 6. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of pluripotent stem cell for personalized cell therapies against neurological disorders.
    Ha HY; Jang SH; Jung JW
    J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
    Yoshida Y; Yamanaka S
    Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods of Generation of Induced Pluripotent Stem Cells and Their Application for the Therapy of Central Nervous System Diseases.
    Cherkashova EA; Leonov GE; Namestnikova DD; Solov'eva AA; Gubskii IL; Bukharova TB; Gubskii LV; Goldstein DV; Yarygin KN
    Bull Exp Biol Med; 2020 Feb; 168(4):566-573. PubMed ID: 32157511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An eye to the future: Researchers debate best path for stem cell-derived therapies.
    Chakradhar S
    Nat Med; 2016 Feb; 22(2):116-9. PubMed ID: 26845400
    [No Abstract]   [Full Text] [Related]  

  • 13. Personalized therapeutic strategies for patients with retinitis pigmentosa.
    Zheng A; Li Y; Tsang SH
    Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising new sources for pluripotent stem cells.
    Leeb C; Jurga M; McGuckin C; Moriggl R; Kenner L
    Stem Cell Rev Rep; 2010 Mar; 6(1):15-26. PubMed ID: 20091142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting stem cells to the test.
    Dolgin E
    Nat Med; 2010 Dec; 16(12):1354-7. PubMed ID: 21135828
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling.
    Koch P; Kokaia Z; Lindvall O; Brüstle O
    Lancet Neurol; 2009 Sep; 8(9):819-29. PubMed ID: 19679274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineering strategies to accelerate stem cell therapeutics.
    Madl CM; Heilshorn SC; Blau HM
    Nature; 2018 May; 557(7705):335-342. PubMed ID: 29769665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.
    Loperfido M; Steele-Stallard HB; Tedesco FS; VandenDriessche T
    Curr Gene Ther; 2015; 15(4):364-80. PubMed ID: 26122099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.
    Mack DL; Guan X; Wagoner A; Walker SJ; Childers MK
    Am J Phys Med Rehabil; 2014 Nov; 93(11 Suppl 3):S155-68. PubMed ID: 25122102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular alchemy: induced pluripotent stem cells retain epigenetic memory.
    Jandial R; Levy ML
    World Neurosurg; 2011 Jan; 75(1):5-6. PubMed ID: 21492641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.